Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC) (EVACARNEY)

This study has been completed.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: April 25, 2008
Last updated: July 5, 2016
Last verified: July 2016